Qualigen Therapeutics (QLGN) Competitors $3.71 -0.11 (-2.88%) Closing price 03:59 PM EasternExtended Trading$3.71 0.00 (0.00%) As of 05:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock QLGN vs. BGXX, CLDI, ATHA, AYTU, HOTH, NERV, PHXM, HCWB, DWTX, and LSBShould you be buying Qualigen Therapeutics stock or one of its competitors? The main competitors of Qualigen Therapeutics include Bright Green (BGXX), Calidi Biotherapeutics (CLDI), Athira Pharma (ATHA), Aytu BioPharma (AYTU), Hoth Therapeutics (HOTH), Minerva Neurosciences (NERV), PHAXIAM Therapeutics (PHXM), HCW Biologics (HCWB), Dogwood Therapeutics (DWTX), and Lakeshore Biopharma (LSB). These companies are all part of the "pharmaceutical products" industry. Qualigen Therapeutics vs. Its Competitors Bright Green Calidi Biotherapeutics Athira Pharma Aytu BioPharma Hoth Therapeutics Minerva Neurosciences PHAXIAM Therapeutics HCW Biologics Dogwood Therapeutics Lakeshore Biopharma Qualigen Therapeutics (NASDAQ:QLGN) and Bright Green (NASDAQ:BGXX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, analyst recommendations, community ranking, valuation, profitability, dividends and risk. Which has stronger earnings & valuation, QLGN or BGXX? Bright Green has lower revenue, but higher earnings than Qualigen Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQualigen Therapeutics$4.98M0.55-$13.42MN/AN/ABright GreenN/AN/A-$13.13M-$0.06N/A Does the MarketBeat Community prefer QLGN or BGXX? Qualigen Therapeutics received 7 more outperform votes than Bright Green when rated by MarketBeat users. CompanyUnderperformOutperformQualigen TherapeuticsOutperform Votes787.50% Underperform Votes112.50%Bright GreenN/AN/A Do insiders and institutionals hold more shares of QLGN or BGXX? 3.2% of Qualigen Therapeutics shares are owned by institutional investors. Comparatively, 7.8% of Bright Green shares are owned by institutional investors. 1.8% of Qualigen Therapeutics shares are owned by company insiders. Comparatively, 62.5% of Bright Green shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more volatility & risk, QLGN or BGXX? Qualigen Therapeutics has a beta of 0.01, suggesting that its stock price is 99% less volatile than the S&P 500. Comparatively, Bright Green has a beta of -0.26, suggesting that its stock price is 126% less volatile than the S&P 500. Does the media prefer QLGN or BGXX? In the previous week, Qualigen Therapeutics had 1 more articles in the media than Bright Green. MarketBeat recorded 1 mentions for Qualigen Therapeutics and 0 mentions for Bright Green. Qualigen Therapeutics' average media sentiment score of 1.89 beat Bright Green's score of 0.00 indicating that Qualigen Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Qualigen Therapeutics Very Positive Bright Green Neutral Is QLGN or BGXX more profitable? Qualigen Therapeutics' return on equity of 0.00% beat Bright Green's return on equity.Company Net Margins Return on Equity Return on Assets Qualigen TherapeuticsN/A N/A -424.18% Bright Green N/A -88.37%-55.30% SummaryQualigen Therapeutics beats Bright Green on 6 of the 10 factors compared between the two stocks. Get Qualigen Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for QLGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding QLGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QLGN vs. The Competition Export to ExcelMetricQualigen TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.73M$6.85B$5.56B$8.50BDividend YieldN/A2.53%5.28%4.17%P/E RatioN/A8.4326.6419.64Price / Sales0.55262.52407.99152.17Price / CashN/A65.8538.2534.64Price / Book-0.186.536.974.60Net Income-$13.42M$143.25M$3.23B$248.06M7 Day Performance-1.07%0.21%-0.98%-1.03%1 Month Performance-0.27%10.92%7.70%3.50%1 Year Performance-61.57%2.44%31.32%12.68% Qualigen Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QLGNQualigen TherapeuticsN/A$3.71-2.9%N/A-63.5%$2.73M$4.98M0.0050Positive NewsBGXXBright GreenN/AN/AN/AN/A$11.47MN/A-1.002Gap DownCLDICalidi Biotherapeutics1.5077 of 5 stars$0.35-1.2%$10.00+2,790.2%N/A$11.14M$50K0.0038High Trading VolumeATHAAthira Pharma2.8801 of 5 stars$0.29-8.8%$13.83+4,752.1%-88.1%$11.13MN/A-0.1040Gap DownAYTUAytu BioPharma1.47 of 5 stars$1.78flatN/A-34.3%$10.98M$81.66M-1.23160Short Interest ↓HOTHHoth Therapeutics3.1965 of 5 stars$0.93+12.0%$4.00+330.1%+43.7%$10.97MN/A-0.704News CoverageAnalyst ForecastShort Interest ↓NERVMinerva Neurosciences3.3986 of 5 stars$1.56+1.3%$5.00+220.5%-45.1%$10.91MN/A-3.559Positive NewsPHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58M$32.66M0.0049News CoverageHCWBHCW Biologics3.4126 of 5 stars$7.21-6.7%$35.00+385.4%-87.5%$10.38M$1.45M-7.2140Short Interest ↓Gap DownDWTXDogwood Therapeutics2.0114 of 5 stars$5.27+1.7%$10.00+89.8%N/A$10.07MN/A-0.805Positive NewsLSBLakeshore Biopharma0.6345 of 5 stars$1.07flatN/AN/A$9.96M$672.27M0.00773 Related Companies and Tools Related Companies BGXX Competitors CLDI Competitors ATHA Competitors AYTU Competitors HOTH Competitors NERV Competitors PHXM Competitors HCWB Competitors DWTX Competitors LSB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:QLGN) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qualigen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Qualigen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy QLGN Stock Free QLGN Stock Alerts